Sign in

CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company

Tectonic Therapeutic, Inc.

Sign in to watch
Ticker
TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
810710585
Phone
(339) 666-3320
Business address
490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Former names
AvroBio, Inc., AVROBIO, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,920
in 2 filings, $14K under 10b5-1 plans

Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McNamara Peter −$14K Chief Scientific Officer sold 1% of stake

Reading 86 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-04 REICIN ALISE Chief Executive Officer Shares withheld for taxes −4,104 $23.22 $95K 235,047
2025-12-31 REICIN ALISE Chief Executive Officer Option exercise +10,966 $2.38 $26K 239,151
2025-12-31 REICIN ALISE Chief Executive Officer Option exercise · Employee Stock Option (Right to Buy) −10,966 22,957
2025-12-22 McNamara Peter Chief Scientific Officer Option exercise +7,000 $2.98 $21K 40,879
2025-12-22 McNamara Peter Chief Scientific Officer Option exercise · Employee Stock Option (Right to Buy) −7,000 25,065
2025-09-25 Ruddy Marcella K. Chief Medical Officer Grant or award +5,370 55,311
2025-09-25 Ruddy Marcella K. Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +9,750 9,750
2025-09-25 McNamara Peter Chief Scientific Officer Grant or award +4,550 33,879
2025-09-25 McNamara Peter Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +8,260 8,260
2025-09-25 Schwabish Marc Chief Business Officer Grant or award +4,210 22,933
2025-09-25 Schwabish Marc Chief Business Officer Grant or award · Employee Stock Option (Right to Buy) +7,650 7,650
2025-09-25 Lochner Daniel Chief Financial Officer Grant or award +5,430 28,121
2025-09-25 Lochner Daniel Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +9,860 9,860
2025-09-25 REICIN ALISE Chief Executive Officer Grant or award +14,700 228,185
2025-09-25 REICIN ALISE Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +26,710 26,710
2025-06-20 REICIN ALISE Chief Executive Officer Shares withheld for taxes −859 $19.81 $17K 213,485
2025-06-09 Donenberg Phillip B. Director Grant or award · Stock Option (Right to Buy) +10,200 10,200
2025-06-09 Vitorovic Stefan Director Grant or award · Stock Option (Right to Buy) +10,200 10,200
2025-06-09 MCGUIRE TERRANCE Director Grant or award · Stock Option (Right to Buy) +10,200 10,200
2025-06-09 Tipirneni Praveen P. Director Grant or award · Stock Option (Right to Buy) +10,200 10,200

Page 4 of 10 · 188 trades